SlideServe
Menu
Préférences
© SlideServe · v2026

Essential Medicines Programmes Sudan now

vanig avatar
13 diapositives · 429 Views · Aug 01, 2014

Essential Medicines Programmes Sudan now. Now : Essential Medicines programmes. In 2010 , health expenditures The public per capita expenditure is US$ 40, . Now: NDP. The NDP is increasingly act as a framework for managing the pharmaceutical sector. . Now: Essential Medicines.

Essential Medicines Programmes Sudan now - slide 1
01 / 13Essential Medicines Programmes Sudan now
1 / 17

Télécharger la présentation

Essential Medicines Programmes Sudan now
Une image / un lien ci-dessous est fourni (tel quel) pour télécharger la présentation

Politique de téléchargement : le contenu du site vous est fourni TEL QUEL pour votre information et votre usage personnel ; il ne peut être vendu, concédé sous licence ni partagé sur d’autres sites sans l’accord de son auteur.Le contenu vous est fourni TEL QUEL, pour votre information et votre usage personnel uniquement. Téléchargez la présentation en cliquant sur ce lien. Lors du téléchargement, si vous ne parvenez pas à télécharger une présentation, l’éditeur a peut-être supprimé le fichier de son serveur.Pendant le téléchargement, si vous ne parvenez pas à obtenir une présentation, le fichier a peut-être été supprimé par l’éditeur.

F I N

Plus de contenu associé

Transcription de la présentation
  1. Essential Medicines Programmes Sudan now

  2. Now: EssentialMedicinesprogrammes In 2010 , health expenditures • The public per capita expenditure is US$ 40,

  3. Now: NDP • The NDP is increasingly act as a framework for managing the pharmaceutical sector.

  4. Now: Essential Medicines • It guides the procurement of medicines in the public sector, health insurance, donations, and local medicine production. • It is part of training programme of graduated pharmacists. • Today, both public tender prices and C&F prices for private sector are publically available in websites.

  5. Now: Public SupplySystem • Management system improved significantly • Computerized system at central • SOPs and adherence to basic standards in drug supply management • Monitoring and evaluation systems, • Managerial auditing system • Delivery to states through RDF project • Branch in each state with 8% less in price;

  6. Now: Health Insurance • Coverage is only 30% of population; • Based on essential medicines; • Patient pay 25% of the treatment cost; • Branch in each state

  7. Now: Health Partners • Obtaining health partners and donors support to expand the drug supply & management component; • GF delivering free medicines for the TB, HIV and Malaria • programmes for control neglected and communicable diseases e.g Meningitis outbreaks, • EPI, • RH • EHA, in areas where the Government is not available

  8. Now: Availability • In 2007, the availability essential medicines in public sector was 86% and 95% in private sector • In 2010, availability of essential medicines at public sector was 80.6%, and in private sector was 93.0% In 2007, only 67 % are affordable.

  9. Now: RUM • In 2007; 73% of prescribed medicines in public sector were from the EML, • 45% were prescribed by generic name

  10. Now: Regulations essential medicines • In 2007, independent MRA was established and Policies separated from regulations; • With support of WHO/EC roadmap for QC PQ is in place since 2008. • Pharmaco-vigilance unit established in 2009; • Being Uppsala member supported by EC

  11. Other changes • WHO Good Governance started in 2010 • Pharmaceutical Country Profile, in 2010 • Global Fund Project for 5-years support • Licensed pharmacists was 1.53/10,000 compared to 0.5/10,000 in 1990, • HR mapping was conducted • framework for HRD developed;

  12. Challenges • Fragmented health system, with inequitable distribution of resources; • Verticality of supplies by different programme • Instability of policies towards public supply system; • Poor data and information management system; • Efficacy and quality, yet is a question; • Distribution and delivery at state level; • Accessibility is still low; • Low coverage of health insurance; • Irrational use of medicines (36% of health expenditures); • Capacities to adsorb all available budgets is limited; • Policies implementation and monitoring

  13. Thank you